Videos
Diagnosing IRDs
Patient Communication
Managing IRD Patients
Future Directions
Podcasts
Podcasts
Part 1
Diagnosing IRDs
In this episode of the EURETINA IME podcast series on the fundamentals of inherited retinal diseases (IRDs), Drs. Maximilian Pfau and Graeme Black explore the complexities of diagnosing IRDs, emphasizing the importance of a multidisciplinary approach. They discuss key diagnostic elements, challenges, and the potential of artificial intelligence to enhance diagnostic efficiency. Be sure to listen to the other podcasts in this series!
Podcasts
Part 2
Patient Communication
In this episode of the EURETINA IME podcast series on the fundamentals of inherited retinal diseases (IRDs), Drs. Maximilian Pfau and Graeme Black discuss key strategies for effectively communicating IRD diagnoses to patients. They address common misconceptions, clarify essential terminology, and emphasize the vital role of genetic counselors in guiding patients towards understanding their diagnosis and making informed choices. Drs. Pfau and Black also highlight the importance of involving family members, connecting with support groups, and utilizing available resources. Be sure to listen to the other podcasts in this series!
Podcasts
Part 3
Managing IRD patients
In this episode of the EURETINA IME podcast series on the fundamentals of inherited retinal diseases (IRDs), Profs. Bart Leroy and Hélène Dollfus underscore the importance of early detection, regular follow-ups, and referrals to specialized centers, enabling IRD patients to receive comprehensive assessments, including functional and genetic testing. They also discuss the effectiveness of current treatments, common barriers to access, and the critical need to boost awareness and education among patients and healthcare providers. Be sure to listen to the other podcasts in this series!
Podcasts
Part 4
Future Directions
In this episode of the EURETINA IME podcast series on the fundamentals of inherited retinal diseases (IRDs), Profs. Bart Leroy and Hélène Dollfus discuss promising treatment strategies, including gene-specific targeted therapies and broader, agnostic approaches that may address multiple genes or underlying pathogenic mechanisms. They also provide an overview of ongoing cell therapy clinical trials and highlight gaps in current clinical care pathways. Be sure to listen to the other podcasts in this series!
Supplements
Independent medical education supported by
Alkeus | Johnson & Johnson | Neurotech
All content has been developed independently by EURETINA